Skip to main content
. 2018 Jul 31;8(8):72. doi: 10.1038/s41408-018-0109-0

Fig. 1.

Fig. 1

A contemporary treatment algorithm in myelofibrosis that employs MIPSS70+ version 2.0 (cytogenetic- and mutation-enhanced international prognostic scoring system for transplant-age patients)